John Renger
2019
In 2019, John Renger earned a total compensation of $2.1M as Chief Scientific Officer at Cerevel Therapeutics Holdings.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Non-Equity Incentive Plan | $151,989 |
| Option Awards | $1,489,792 |
| Salary | $330,411 |
| Other | $26,716 |
| Total | $2,128,908 |
Renger received $1.5M in option awards, accounting for 70% of the total pay in 2019.
Renger also received $130K in bonus, $152K in non-equity incentive plan, $330.4K in salary and $26.7K in other compensation.
Rankings
In 2019, John Renger's compensation ranked 5,606th out of 13,971 executives tracked by ExecPay. In other words, Renger earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,606 out of 13,971 | 60th |
Division Manufacturing | 2,098 out of 5,701 | 63rd |
Major group Chemicals And Allied Products | 748 out of 2,200 | 66th |
Industry group Drugs | 628 out of 1,886 | 67th |
Industry Pharmaceutical Preparations | 460 out of 1,398 | 67th |
Source: SEC filing on April 28, 2021.
Renger's colleagues
We found two more compensation records of executives who worked with John Renger at Cerevel Therapeutics Holdings in 2019.